Latest Share Chat

REMOVE ADS

Skinbiotherap. Share News (SBTX)

Skinbiotherap. Information

Share Price Information for Skinbiotherap. (SBTX)

Share Price is delayed by 15 minutes

Get Live Data

11.50 0.50 (4.55%)

Bid:

11.00

Ask:

12.00

Spread: 1.00 (9.091%)

Market Cap: £29.80m

Last checked at -

Intraday Skinbiotherap. Share Chart

REMOVE ADS

Skinbiotherap. News

SkinBioTherapeutics says ex-CEO "misrepresented material information"

(Alliance News) - Shares in SkinBioTherapeutics PLC plunged on Monday after the company said its probe into the conduct of its former boss will result...

SkinBioTherapeutics dives on warning of major FY25 revenue restatement

(Sharecast News) - Life sciences company SkinBioTherapeutics traded sharply lower early on Monday after revealing an internal investigation had raised...

Market News

LONDON BRIEFING: NatWest starts buyback, Pebble Beach wins contract

(Alliance News) - The FTSE 100 was called higher on Monday, as Beazley extends its deadline for Zurich Insurance to make an acquisition offer.

CORRECT: AIM WINNERS & LOSERS: SkinBioTherapeutics CEO suspended

(Amending company description for EPE Special Opportunities Ltd)

AIM WINNERS & LOSERS: SkinBioTherapeutics sinks as CEO suspended

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

LONDON MARKET OPEN: Shares steady after global AI-led sell-off

(Alliance News) - Stock prices in London opened slightly higher on Friday, as markets steadied following a sharp US and Asian sell-off sparked by rene...

IN BRIEF: SkinBioTherapeutics CEO Ashman resigns amid probe of conduct

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Chief Executive Officer Stuart Ashman resigns ...

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data ...